In palladium sensitive patients, there were significant increases of DRB4 (R.R.= 15.48, p &lt; 0.05), DR4(R.R.= 13.27, p &lt; 0.005), DRB1*0405(R.R.= 4.43, p &lt; 0.05), and DQB1*0401 (R.R.
C0020517
Hypersensitivity